Abstract: In one embodiment, a system includes a processor and logic configured to receive data including a plurality of data elements, each data element having one or more bits, and pass each data element along with a corresponding parity bit to an input of a data path, a first binary sequence generator configured to create a binary sequence having a plurality of bonus bits, wherein a total length of the binary sequence is equal to or greater than a maximum burst size of the data, and a first parity module configured to provide a parity calculation using bits of each data element of the data with a bonus bit from the binary sequence to produce a parity bit for each data element. Other systems, methods, and computer program products for providing end-to-end parity generation and checking that the scheme provides coverage for both data and sequencing faults are also disclosed.

Abstract: Systems and methods for facilitating participation in a remote meeting or virtual conference are described. A client device can detect an upcoming calendar event and, based on a record associated with the calendar event, identify elements for participating in the event, as well as one or more access codes associated with the one or more participation elements. A notification can be displayed to a user, the notification including a prompt for selection by the user to automatically initiate participation in the event. After initiating the user's participation in the event, an interface can be displayed to the user including a link to the access code corresponding to the participation element(s) used to initiate participation in the event. Upon selection of the link, the access code can be automatically provided to the service hosting the event.

Abstract: According to one embodiment, a method includes issuing a read request to read one or more units of data from at least one non-volatile random access memory (NVRAM) device. The read request includes one or more read voltage thresholds. The method also includes receiving the one or more data units and read command parameters used to read the one or more data units from the at least one NVRAM device. Moreover, the method includes storing error-free data units, the read command parameters used to read the error-free data units from the at least one NVRAM device, and a read completion status to one of a plurality of read buffers. The read completion status indicates a completed read when a data unit is error-free and indicates an incomplete read when a data unit is errored.

Abstract: According to one embodiment, a system includes a read buffer memory configured to store data to support integrated XOR reconstructed data and read-retry data and logic configured to receive data units and read command parameters used to read the data units from a non-volatile random access memory (NVRAM) device, determine which read buffers from the read buffer memory to store the data units, determine an error status for each of the data units, wherein the error status indicates whether each data unit includes errored data or error-free data, store each error-free data unit and the read command parameters to a corresponding read buffer, reject each errored data unit without affecting a corresponding read buffer, and retry to read only errored data units from the NVRAM device until each of the data units is stored in the read buffer memory.

Abstract: In one embodiment, a system includes a processor and logic configured to receive data including a plurality of data elements, each data element having one or more bits, and pass each data element along with a corresponding parity bit to an input of a data path, a first binary sequence generator configured to create a binary sequence having a plurality of bonus bits, wherein a total length of the binary sequence is equal to or greater than a maximum burst size of the data, and a first parity module configured to provide a parity calculation using bits of each data element of the data with a bonus bit from the binary sequence to produce a parity bit for each data element. Other systems, methods, and computer program products for providing end-to-end parity generation and checking that the scheme provides coverage for both data and sequencing faults are also disclosed.

Abstract: According to one embodiment, a system includes a read butter memory configured to store data to support integrated XOR reconstructed data and read-retry data and logic configured to receive data units and read command parameters used to read the data units from a non-volatile random access memory (NVRAM) device, determine which read buffers from the read buffer memory to store the data units, determine an error status for each of the data units, wherein the error status indicates whether each data unit includes errored data or error-free data, store each error-free data unit and the read command parameters to a corresponding read buffer, reject each errored data unit without affecting a corresponding read buffer, and retry to read only errored data units from the NVRAM device until each of the data units is stored in the read buffer memory.

Abstract: The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates the lanthanum carbonate or its hydrate and the lubricant. Capsule shells comprise, for example, gelatin. The present invention also includes an oral pharmaceutical powder comprising lanthanum carbonate or lanthanum carbonate hydrate and a pharmaceutically acceptable excipient. The oral pharmaceutical capsules and powders of the present invention can be administered to treat a patient at risk of or suffering from hyperphosphatemia, at risk of or suffering from chronic kidney disease (CKD), at risk of or suffering from soft tissue calcification associated with CKD, or at risk of or suffering from secondary hyperparathyroidism.

Abstract: The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates the lanthanum carbonate or its hydrate and the lubricant. Capsule shells comprise, for example, gelatin. The present invention also includes an oral pharmaceutical powder comprising lanthanum carbonate or lanthanum carbonate hydrate and a pharmaceutically acceptable excipient. The oral pharmaceutical capsules and powders of the present invention can be administered to treat a patient at risk of or suffering from hyperphosphatemia, at risk of or suffering from chronic kidney disease (CKD), at risk of or suffering from soft tissue calcification associated with CKD, or at risk of or suffering from secondary hyperparathyroidism.

Abstract: The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates the lanthanum carbonate or its hydrate and the lubricant. Capsule shells comprise, for example, gelatin. The present invention also includes an oral pharmaceutical powder comprising lanthanum carbonate or lanthanum carbonate hydrate and a pharmaceutically acceptable excipient. The oral pharmaceutical capsules and powders of the present invention can be administered to treat a patient at risk of or suffering from hyperphosphatemia, at risk of or suffering from chronic kidney disease (CKD), at risk of or suffering from soft tissue calcification associated with CKD, or at risk of or suffering from secondary hyperparathyroidism.

Abstract: The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates the lanthanum carbonate or its hydrate and the lubricant. Capsule shells comprise, for example, gelatin. The present invention also includes an oral pharmaceutical powder comprising lanthanum carbonate or lanthanum carbonate hydrate and a pharmaceutically acceptable excipient. The oral pharmaceutical capsules and powders of the present invention can be administered to treat a patient at risk of or suffering from hyperphosphatemia, at risk of or suffering from chronic kidney disease (CKD), at risk of or suffering from soft tissue calcification associated with CKD, or at risk of or suffering from secondary hyperparathyroidism.

Abstract: In at least one illustrative embodiment, a fluid flow control apparatus may comprise a fluid network including a plurality of parallel branches, each parallel branch of the plurality of parallel branches being fluidly coupled between an inlet and an outlet of the fluid network. Each parallel branch of the plurality of parallel branches may comprise a pressure-independent flow control device configured to limit fluid flow through the respective parallel branch to a reference flow amount irrespective of a pressure at the inlet of the fluid network.

Abstract: A de-mapping circuit for de-mapping input words of a first length into output words of a second length different from the first length. In one embodiment, the circuit includes a word register of the first length and temporary registers of the second length. The word register successively stores each of the inputs words in response to cycles of a clock. The temporary registers temporarily store the output words. Multiplexers configured by address signals select bits from stored input words and store the selected bits into the temporary registers to form temporarily stored output words.

Abstract: The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates the lanthanum carbonate or its hydrate and the lubricant. Capsule shells comprise, for example, gelatin. The present invention also includes an oral pharmaceutical powder comprising lanthanum carbonate or lanthanum carbonate hydrate and a pharmaceutically acceptable excipient. The oral pharmaceutical capsules and powders of the present invention can be administered to treat a patient at risk of or suffering from hyperphosphatemia, at risk of or suffering from chronic kidney disease (CKD), at risk of or suffering from soft tissue calcification associated with CKD, or at risk of or suffering from secondary hyperparathyroidism.

Abstract: The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates the lanthanum carbonate or its hydrate and the lubricant. Capsule shells comprise, for example, gelatin. The present invention also includes an oral pharmaceutical powder comprising lanthanum carbonate or lanthanum carbonate hydrate and a pharmaceutically acceptable excipient. The oral pharmaceutical capsules and powders of the present invention can be administered to treat a patient at risk of or suffering from hyperphosphatemia, at risk of or suffering from chronic kidney disease (CKD), at risk of or suffering from soft tissue calcification associated with CKD, or at risk of or suffering from secondary hyperparathyroidism.

Abstract: The present invention relates to a flooring module for forming a floor, and which also incorporates a photovoltaic cell for generating electricity. The floor and electrical generator module has a body comprising: a floor surface for forming a floor; and at least one photovoltaic cell; the module further comprising a support means supporting the body and allowing movement of the body between first and second positions; wherein the module is configured such that the body can function either as a floor in the first position when the floor surface is uppermost or as an electrical generator in the second position when the photovoltaic cell is uppermost.

Abstract: The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates the lanthanum carbonate or its hydrate and the lubricant. Capsule shells comprise, for example, gelatin. The present invention also includes an oral pharmaceutical powder comprising lanthanum carbonate or lanthanum carbonate hydrate and a pharmaceutically acceptable excipient. The oral pharmaceutical capsules and powders of the present invention can be administered to treat a patient at risk of or suffering from hyperphosphatemia, at risk of or suffering from chronic kidney disease (CKD), at risk of or suffering from soft tissue calcification associated with CKD, or at risk of or suffering from secondary hyperparathyroidism.

Abstract: A mapping circuit is provided for mapping first data words into frames of second data words, wherein the first and second data words are of different length. In addition, a de-mapping circuit is provided for de-mapping the frames of second data words into the first data words. The mapping and de-mapping is responsive to address signals that may be stored in a memory such that a desired mapping or de-mapping corresponds to a particular programming of the memory. In this fashion, the mapping and de-mapping is in-system reconfigurable.

Abstract: A check-in system for receiving and transporting luggage from a passenger comprising a conveyor for transporting luggage. The conveyor having a top surface on which luggage is received and which extends from a front end to a rear end, a floor being adjacent to the front end of the conveyor for supporting a passenger. The top surface of the front end of the conveyor is substantially flush with the floor such that luggage may be slid from the floor onto the conveyor.

Abstract: A process for molding recyclable, compostable, and disposable containers made of pulp paper is disclosed herein. The process includes disposing a wet pulp layer on a male or female mold, mating the mold with its counterpart, and applying a force on the pulp layer to remove moisture and thin the pulp. The process continues by applying a vacuum to either the male or female mold to hold the pulp layer, and removing the other mold. The process further comprises sequentially mating male and female molds until the pulp layer is the desired thickness and shape of the container. Embodiments of the process may include molding pulp containers to include pleats, stability features, reverse draft features, and puffed pulp configurations.

Abstract: Methods for making a molded beverage container insulator from a slurry including water and a polysaccharide by presenting at least one male mold, which may have an elliptical cross section, therein and causing a portion of the slurry to temporarily adhere to the at least one mold. After a suitable period of time, removing the mold from the slurry and then removing the insulator. At such time, and particularly if the mold is not characterized as elliptical in cross section, the insulator is subject to bidirectional compression in order to collapse the same. Opposing hinge elements may be formed in the insulator, either at the time of molding or subsequently, to localize stresses resulting from the collapsing of the insulator. The resulting insulator is fully recyclable/compostable and possesses a constricting bias to mitigate container slip issues.